Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug recognized in Canada for managing Attention-Deficit/Hyperactivity Disorder (ADHD) in individuals and adults . It's functions as a prodrug, meaning it’s inactive until broken down by the body, releasing dextroamphetamine steadily over an exte